Microbiome Therapeutics

MRM Health's MH002 Receives FDA Fast Track Designation for Ulcerative Colitis Treatment

MRM Health's lead microbiome therapeutic MH002 granted FDA Fast Track status for mild-to-moderate ulcerative colitis, accelerating development timeline.